PRINTED PDF/ORIGINAL DIRECTLY FROM PUBLISHER/ 100%
VERIFIED ANSWERS/ DOWNLOAD IMMEDIATELY AFTER THE ORDER
, Table of Contents
m m
Chapter m01: mOrientation mto mPharmacology ........................................................................................................................ 5
Chapter m02: mApplication mof mPharmacology min mNursing mPractice ...................................................................................... 6
Chapter m03: mDrug mRegulation, mDevelopment, mNames, mand mInformation ........................................................................ 11
Chapter m04: mPharmacokinetics ......................................................................................................................................... 14
Chapter m05: mPharmacodynamics ...................................................................................................................................... 19
Chapter m06: mDrug mInteractions ......................................................................................................................................... 21
Chapter m07: mAdverse mDrug mReactions mand mMedication mErrors....................................................................................... 26
Chapter m08: mIndividual mVariation mTo mDrug mResponses .................................................................................................. 31
Chapter m09: mGenetic mand mGenomic mConsiderations ........................................................................................................ 35
Chapter m10: mIntroduction mto mImmunomodulators ............................................................................................................ 38
Chapter m11: mDrug mTherapy mDuring mPregnancy mand mBreast-Feeding.............................................................................. 41
Chapter m12: mDrug mTherapy min mPediatric mPatients............................................................................................................ 44
Chapter m13: mDrug mTherapy min mOlder mAdults................................................................................................................... 48
Chapter m14: mBasic mPrinciples mof mNeuropharmacology .................................................................................................... 53
Chapter m15: mPhysiology mof mthe mPeripheral mNervous mSystem .......................................................................................... 56
Chapter m16: mMuscarinic mAgonists .................................................................................................................................... 59
Chapter m17: mMuscarinic mAntagonists ............................................................................................................................... 62
Chapter m18: mCholinesterase mInhibitors mand mTheir mUse min mMyasthenia mGravis .............................................................. 65
Chapter m19: mDrugs mThat mBlock mNicotinic mCholinergic mTransmission ............................................................................ 68
Chapter m20: mAdrenergic mAgonists.................................................................................................................................... 72
Chapter m21: mAdrenergic mAntagonists ............................................................................................................................... 76
Chapter m 22: mIndirect-Acting mAntiadrenergic m Agents ...................................................................................................... 83
Chapter m23: mIntroduction mto mCentral mNervous mSystem mPharmacology........................................................................... 87
Chapter m24: mDrugs mfor mParkinson mDisease ...................................................................................................................... 90
Chapter m25: mDrugs mfor mAlzheimer mDisease ..................................................................................................................... 95
Chapter m26: mDrugs mfor mMultiple mSclerosis ...................................................................................................................... 99
Chapter m27: mDrugs mfor mSeizure mDisorders ..................................................................................................................... 104
Chapter m28: mDrugs mfor mMuscle mSpasm mand mSpasticity ................................................................................................. 111
Chapter m29: mLocal mAnesthetics ...................................................................................................................................... 114
Chapter m30: mGeneral mAnesthetics .................................................................................................................................. 118
Chapter m31: mOpioid mAnalgesics, mOpioid mAntagonists, mand mNonopioid mCentrally mActingAnalgesics ........................... 124
Chapter m32: mPain mManagement min mPatients mwith mCancer ............................................................................................. 129
Chapter m33: mDrugs mfor mHeadache .................................................................................................................................. 136
Chapter m34: mAntipsychotic mAgents mand mTheir mUse min mSchizophrenia.......................................................................... 140
Chapter m35: mAntidepressants .......................................................................................................................................... 146
Chapter m36: mDrugs mfor mBipolar mDisorder ...................................................................................................................... 152
Chapter m37: mSedative-Hypnotic m Drugs .......................................................................................................................... 157
Chapter m38: mManagement mof mAnxiety mDisorders .......................................................................................................... 162
Chapter m39: mCentral mNervous mSystem mStimulants mand mAttention-Deficit/HyperactivityDisorder ................................ 166
Chapter m40: mSubstance mUse mDisorders mI: mBasic mConsiderations................................................................................... 170
Chapter m41: mSubstance mUse mDisorders mII: mAlcohol ....................................................................................................... 174
,Chapter m42: msubstance muse mdisorders miii: mNicotine ....................................................................................................... 180
Chapter m43: msubstance muse mdisorders miv: mMajor mDrugs mof mAbuse mOther mThan mAlcohol mandNicotine ....................... 184
Chapter m44: mDiuretics .................................................................................................................................................... 190
Chapter m45: mAgents mAffecting mthe mVolume mand mIon mContent mof mBody mFluids........................................................... 194
Chapter m46: mReview mof mHemodynamics........................................................................................................................ 199
Chapter m47: mDrugs mActing mon mthe mRenin-Angiotensin-Aldosterone mSystem................................................................ 201
Chapter m48: mCalcium mChannel mBlockers ....................................................................................................................... 206
Chapter m49: mVasodilators ............................................................................................................................................... 208
Chapter m50: mDrugs mfor mHypertension ............................................................................................................................ 212
Chapter m51: mDrugs mfor mHeart mFailure ............................................................................................................................ 219
Chapter m52: mAntidysrhythmic mDrugs ............................................................................................................................. 226
Chapter m53: mDrugs mThat mHelp mNormalize mCholesterol mand mTriglyceride mLevels ........................................................ 233
Chapter m54: mDrugs mfor mAngina mPectoris ....................................................................................................................... 239
Chapter m55: mAnticoagulant, mAntiplatelet, mand mThrombolytic mDrugs ............................................................................. 245
Chapter m56: mManagement mof mST-Elevation mMyocardial mInfarction .............................................................................. 252
Chapter m57: mDrugs mfor mHemophilia ............................................................................................................................... 256
Chapter m58: mDrugs mfor mDeficiency mAnemias ................................................................................................................ 260
Chapter m59: mHematopoietic mAgents ............................................................................................................................... 266
Chapter m60: mDrugs mfor mDiabetes mMellitus ..................................................................................................................... 270
Chapter m61: mDrugs mfor mThyroid mDisorders.................................................................................................................... 276
Chapter m62: mDrugs mRelated mto mHypothalamic mand mPituitary mFunction ......................................................................... 281
Chapter m63: mDrugs mfor mDisorders mof mthe mAdrenal mCortex ............................................................................................ 285
Chapter m64: mEstrogens mand mProgestins: mBasic mPharmacology mand mNoncontraceptiveApplications ............................. 289
Chapter m65: mBirth mControl ............................................................................................................................................. 293
Chapter m66: mDrug mTherapy mfor mInfertility ..................................................................................................................... 298
Chapter m67: mDrugs mThat mAffect mUterine mFunction........................................................................................................ 302
Chapter m68: mAndrogens.................................................................................................................................................. 307
Chapter m69: mDrugs mfor mErectile mDysfunction mand mBenign mProstatic mHyperplasia ....................................................... 311
Chapter m70: mReview mof mthe mImmune mSystem ............................................................................................................... 315
Chapter m71: mChildhood mImmunization........................................................................................................................... 319
Chapter m72: mImmunosuppressants .................................................................................................................................. 324
Chapter m73: mAntihistamines ........................................................................................................................................... 328
Chapter m74: mCyclooxygenase mInhibitors, mNonsteroidal mAnti-inflammatory mDrugs mandAcetaminophen ....................... 333
Chapter m75: mGlucocorticoids min mNonendocrine mDisorders............................................................................................. 338
Chapter m76: mDrug mTherapy mfor mRheumatoid mArthritis .................................................................................................. 344
Chapter m77: mDrug mTherapy mfor mGout ............................................................................................................................ 347
Chapter m78: mDrugs mAffecting mCalcium mLevels mand mBone mMineralization ................................................................... 350
Chapter m79: mDrugs mfor mAsthma mand mChronic mObstructive mPulmonary mDisease ........................................................... 356
Chapter m80: mDrugs mfor mAllergic mRhinitis, mCough, mand mColds ...................................................................................... 363
Chapter m81: mDrugs mfor mPeptic mUlcer mDisease ............................................................................................................... 368
Chapter m82: mLaxatives.................................................................................................................................................... 373
Chapter m83: mOther mGastrointestinal mDrugs ..................................................................................................................... 378
Chapter m84: mVitamins .................................................................................................................................................... 385
, Chapter m85: mDrugs mfor mWeight mLoss............................................................................................................................. 391
Chapter m86: mComplementary mand mAlternative mTherapy................................................................................................. 396
Chapter m87: mBasic mPrinciples mof mAntimicrobial mTherapy.............................................................................................. 399
Chapter m88: mDrugs mThat mWeaken mthe mBacterial mCell mWall mI: mPenicillins ................................................................... 404
Chapter m89: mDrugs mThat mWeaken mthe mBacterial mCell mWall mII: mOther mDrugs .............................................................. 409
Chapter m90: mBacteriostatic mInhibitors mof mProtein mSynthesis: mTetracyclines, mMacrolides, mandOthers ........................... 413
Chapter m91: mAminoglycosides: mBactericidal mInhibitors mof mProtein mSynthesis .............................................................. 421
Chapter m92: mSulfonamides mand mTrimethoprim .............................................................................................................. 427
Chapter m93: mDrug mTherapy mfor mUrinary mTract mInfections............................................................................................. 431
Chapter m94: mAntimycobacterial mAgents ......................................................................................................................... 437
Chapter m95: mMiscellaneous mAntibacterial mDrugs ........................................................................................................... 444
Chapter m96: mAntifungal mAgents ..................................................................................................................................... 448
Chapter m97: mAntiviral mAgents mI: mDrugs mfor mNon-HIV mViral mInfections ...................................................................... 455
Chapter m98: mAntiviral mAgents mII: mDrugs mfor mHIV mInfection mand mRelated mOpportunisticInfections ............................ 460
Chapter m99: mDrug mTherapy mfor mSexually mTransmitted mDiseases .................................................................................. 465
Chapter m100: mAntiseptics mand mDisinfectants .................................................................................................................. 469
Chapter m101: mAnthelmintics ........................................................................................................................................... 473
Chapter m102: mAntiprotozoal mDrugs mI: mAntimalarial mAgents .......................................................................................... 476
Chapter m103: mAntiprotozoal mDrugs mII: mMiscellaneous mAgents ..................................................................................... 481
Chapter m104: mEctoparasiticides ...................................................................................................................................... 483
Chapter m105: mBasic mPrinciples mof mCancer mChemotherapy ............................................................................................ 487
Chapter m106: mAnticancer mDrugs mI: mCytotoxic mAgents................................................................................................... 493
Chapter m107: mAnticancer mDrugs mII: mNoncytotoxic mAgents ........................................................................................... 498
Chapter m108: mDrugs mfor mthe mEye ................................................................................................................................... 502
Chapter m109: mDrugs mfor mthe mSkin .................................................................................................................................. 507
Chapter m110: mDrugs mfor mthe mEar.................................................................................................................................... 514
Chapter m111: mManagement mof mPoisoning ...................................................................................................................... 519
Chapter m112: mPotential mWeapons mof mBiologic, mRadiologic, mand mChemical mTerrorism ................................................. 523
VERIFIED ANSWERS/ DOWNLOAD IMMEDIATELY AFTER THE ORDER
, Table of Contents
m m
Chapter m01: mOrientation mto mPharmacology ........................................................................................................................ 5
Chapter m02: mApplication mof mPharmacology min mNursing mPractice ...................................................................................... 6
Chapter m03: mDrug mRegulation, mDevelopment, mNames, mand mInformation ........................................................................ 11
Chapter m04: mPharmacokinetics ......................................................................................................................................... 14
Chapter m05: mPharmacodynamics ...................................................................................................................................... 19
Chapter m06: mDrug mInteractions ......................................................................................................................................... 21
Chapter m07: mAdverse mDrug mReactions mand mMedication mErrors....................................................................................... 26
Chapter m08: mIndividual mVariation mTo mDrug mResponses .................................................................................................. 31
Chapter m09: mGenetic mand mGenomic mConsiderations ........................................................................................................ 35
Chapter m10: mIntroduction mto mImmunomodulators ............................................................................................................ 38
Chapter m11: mDrug mTherapy mDuring mPregnancy mand mBreast-Feeding.............................................................................. 41
Chapter m12: mDrug mTherapy min mPediatric mPatients............................................................................................................ 44
Chapter m13: mDrug mTherapy min mOlder mAdults................................................................................................................... 48
Chapter m14: mBasic mPrinciples mof mNeuropharmacology .................................................................................................... 53
Chapter m15: mPhysiology mof mthe mPeripheral mNervous mSystem .......................................................................................... 56
Chapter m16: mMuscarinic mAgonists .................................................................................................................................... 59
Chapter m17: mMuscarinic mAntagonists ............................................................................................................................... 62
Chapter m18: mCholinesterase mInhibitors mand mTheir mUse min mMyasthenia mGravis .............................................................. 65
Chapter m19: mDrugs mThat mBlock mNicotinic mCholinergic mTransmission ............................................................................ 68
Chapter m20: mAdrenergic mAgonists.................................................................................................................................... 72
Chapter m21: mAdrenergic mAntagonists ............................................................................................................................... 76
Chapter m 22: mIndirect-Acting mAntiadrenergic m Agents ...................................................................................................... 83
Chapter m23: mIntroduction mto mCentral mNervous mSystem mPharmacology........................................................................... 87
Chapter m24: mDrugs mfor mParkinson mDisease ...................................................................................................................... 90
Chapter m25: mDrugs mfor mAlzheimer mDisease ..................................................................................................................... 95
Chapter m26: mDrugs mfor mMultiple mSclerosis ...................................................................................................................... 99
Chapter m27: mDrugs mfor mSeizure mDisorders ..................................................................................................................... 104
Chapter m28: mDrugs mfor mMuscle mSpasm mand mSpasticity ................................................................................................. 111
Chapter m29: mLocal mAnesthetics ...................................................................................................................................... 114
Chapter m30: mGeneral mAnesthetics .................................................................................................................................. 118
Chapter m31: mOpioid mAnalgesics, mOpioid mAntagonists, mand mNonopioid mCentrally mActingAnalgesics ........................... 124
Chapter m32: mPain mManagement min mPatients mwith mCancer ............................................................................................. 129
Chapter m33: mDrugs mfor mHeadache .................................................................................................................................. 136
Chapter m34: mAntipsychotic mAgents mand mTheir mUse min mSchizophrenia.......................................................................... 140
Chapter m35: mAntidepressants .......................................................................................................................................... 146
Chapter m36: mDrugs mfor mBipolar mDisorder ...................................................................................................................... 152
Chapter m37: mSedative-Hypnotic m Drugs .......................................................................................................................... 157
Chapter m38: mManagement mof mAnxiety mDisorders .......................................................................................................... 162
Chapter m39: mCentral mNervous mSystem mStimulants mand mAttention-Deficit/HyperactivityDisorder ................................ 166
Chapter m40: mSubstance mUse mDisorders mI: mBasic mConsiderations................................................................................... 170
Chapter m41: mSubstance mUse mDisorders mII: mAlcohol ....................................................................................................... 174
,Chapter m42: msubstance muse mdisorders miii: mNicotine ....................................................................................................... 180
Chapter m43: msubstance muse mdisorders miv: mMajor mDrugs mof mAbuse mOther mThan mAlcohol mandNicotine ....................... 184
Chapter m44: mDiuretics .................................................................................................................................................... 190
Chapter m45: mAgents mAffecting mthe mVolume mand mIon mContent mof mBody mFluids........................................................... 194
Chapter m46: mReview mof mHemodynamics........................................................................................................................ 199
Chapter m47: mDrugs mActing mon mthe mRenin-Angiotensin-Aldosterone mSystem................................................................ 201
Chapter m48: mCalcium mChannel mBlockers ....................................................................................................................... 206
Chapter m49: mVasodilators ............................................................................................................................................... 208
Chapter m50: mDrugs mfor mHypertension ............................................................................................................................ 212
Chapter m51: mDrugs mfor mHeart mFailure ............................................................................................................................ 219
Chapter m52: mAntidysrhythmic mDrugs ............................................................................................................................. 226
Chapter m53: mDrugs mThat mHelp mNormalize mCholesterol mand mTriglyceride mLevels ........................................................ 233
Chapter m54: mDrugs mfor mAngina mPectoris ....................................................................................................................... 239
Chapter m55: mAnticoagulant, mAntiplatelet, mand mThrombolytic mDrugs ............................................................................. 245
Chapter m56: mManagement mof mST-Elevation mMyocardial mInfarction .............................................................................. 252
Chapter m57: mDrugs mfor mHemophilia ............................................................................................................................... 256
Chapter m58: mDrugs mfor mDeficiency mAnemias ................................................................................................................ 260
Chapter m59: mHematopoietic mAgents ............................................................................................................................... 266
Chapter m60: mDrugs mfor mDiabetes mMellitus ..................................................................................................................... 270
Chapter m61: mDrugs mfor mThyroid mDisorders.................................................................................................................... 276
Chapter m62: mDrugs mRelated mto mHypothalamic mand mPituitary mFunction ......................................................................... 281
Chapter m63: mDrugs mfor mDisorders mof mthe mAdrenal mCortex ............................................................................................ 285
Chapter m64: mEstrogens mand mProgestins: mBasic mPharmacology mand mNoncontraceptiveApplications ............................. 289
Chapter m65: mBirth mControl ............................................................................................................................................. 293
Chapter m66: mDrug mTherapy mfor mInfertility ..................................................................................................................... 298
Chapter m67: mDrugs mThat mAffect mUterine mFunction........................................................................................................ 302
Chapter m68: mAndrogens.................................................................................................................................................. 307
Chapter m69: mDrugs mfor mErectile mDysfunction mand mBenign mProstatic mHyperplasia ....................................................... 311
Chapter m70: mReview mof mthe mImmune mSystem ............................................................................................................... 315
Chapter m71: mChildhood mImmunization........................................................................................................................... 319
Chapter m72: mImmunosuppressants .................................................................................................................................. 324
Chapter m73: mAntihistamines ........................................................................................................................................... 328
Chapter m74: mCyclooxygenase mInhibitors, mNonsteroidal mAnti-inflammatory mDrugs mandAcetaminophen ....................... 333
Chapter m75: mGlucocorticoids min mNonendocrine mDisorders............................................................................................. 338
Chapter m76: mDrug mTherapy mfor mRheumatoid mArthritis .................................................................................................. 344
Chapter m77: mDrug mTherapy mfor mGout ............................................................................................................................ 347
Chapter m78: mDrugs mAffecting mCalcium mLevels mand mBone mMineralization ................................................................... 350
Chapter m79: mDrugs mfor mAsthma mand mChronic mObstructive mPulmonary mDisease ........................................................... 356
Chapter m80: mDrugs mfor mAllergic mRhinitis, mCough, mand mColds ...................................................................................... 363
Chapter m81: mDrugs mfor mPeptic mUlcer mDisease ............................................................................................................... 368
Chapter m82: mLaxatives.................................................................................................................................................... 373
Chapter m83: mOther mGastrointestinal mDrugs ..................................................................................................................... 378
Chapter m84: mVitamins .................................................................................................................................................... 385
, Chapter m85: mDrugs mfor mWeight mLoss............................................................................................................................. 391
Chapter m86: mComplementary mand mAlternative mTherapy................................................................................................. 396
Chapter m87: mBasic mPrinciples mof mAntimicrobial mTherapy.............................................................................................. 399
Chapter m88: mDrugs mThat mWeaken mthe mBacterial mCell mWall mI: mPenicillins ................................................................... 404
Chapter m89: mDrugs mThat mWeaken mthe mBacterial mCell mWall mII: mOther mDrugs .............................................................. 409
Chapter m90: mBacteriostatic mInhibitors mof mProtein mSynthesis: mTetracyclines, mMacrolides, mandOthers ........................... 413
Chapter m91: mAminoglycosides: mBactericidal mInhibitors mof mProtein mSynthesis .............................................................. 421
Chapter m92: mSulfonamides mand mTrimethoprim .............................................................................................................. 427
Chapter m93: mDrug mTherapy mfor mUrinary mTract mInfections............................................................................................. 431
Chapter m94: mAntimycobacterial mAgents ......................................................................................................................... 437
Chapter m95: mMiscellaneous mAntibacterial mDrugs ........................................................................................................... 444
Chapter m96: mAntifungal mAgents ..................................................................................................................................... 448
Chapter m97: mAntiviral mAgents mI: mDrugs mfor mNon-HIV mViral mInfections ...................................................................... 455
Chapter m98: mAntiviral mAgents mII: mDrugs mfor mHIV mInfection mand mRelated mOpportunisticInfections ............................ 460
Chapter m99: mDrug mTherapy mfor mSexually mTransmitted mDiseases .................................................................................. 465
Chapter m100: mAntiseptics mand mDisinfectants .................................................................................................................. 469
Chapter m101: mAnthelmintics ........................................................................................................................................... 473
Chapter m102: mAntiprotozoal mDrugs mI: mAntimalarial mAgents .......................................................................................... 476
Chapter m103: mAntiprotozoal mDrugs mII: mMiscellaneous mAgents ..................................................................................... 481
Chapter m104: mEctoparasiticides ...................................................................................................................................... 483
Chapter m105: mBasic mPrinciples mof mCancer mChemotherapy ............................................................................................ 487
Chapter m106: mAnticancer mDrugs mI: mCytotoxic mAgents................................................................................................... 493
Chapter m107: mAnticancer mDrugs mII: mNoncytotoxic mAgents ........................................................................................... 498
Chapter m108: mDrugs mfor mthe mEye ................................................................................................................................... 502
Chapter m109: mDrugs mfor mthe mSkin .................................................................................................................................. 507
Chapter m110: mDrugs mfor mthe mEar.................................................................................................................................... 514
Chapter m111: mManagement mof mPoisoning ...................................................................................................................... 519
Chapter m112: mPotential mWeapons mof mBiologic, mRadiologic, mand mChemical mTerrorism ................................................. 523
